Chordia Therapeutics Inc…announces that it has executed a termination agreement with Ono Pharmaceutical Co., Ltd. (“Ono”) regarding the license agreement for CTX‑177 (ONO‑7018), a MALT1 inhibitor originating from Chordia’s pipeline

CTX-177 - Chordia Therap

Feb 16, 2026